Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
After finishing at $0.53 in the prior trading day, Catheter Precision Inc (AMEX: VTAK) closed at $0.44, down -17.46%. In other words, the price has decreased by -$17.46 from its previous closing price. On the day, 1.04 million shares were traded. VTAK stock price reached its highest trading level at $0.56 during the session, while it also had its lowest trading level at $0.41.
Ratios:
Our goal is to gain a better understanding of VTAK by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.65 and its Current Ratio is at 0.66. In the meantime, Its Debt-to-Equity ratio is 0.91 whereas as Long-Term Debt/Eq ratio is at 0.88.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Piper Jaffray on August 13, 2019, Downgraded its rating to Neutral and sets its target price to $1.50 from $9 previously.
On November 02, 2018, Maxim Group started tracking the stock assigning a Buy rating and target price of $23.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 23 ’24 when JENKINS DAVID A bought 9,528 shares for $0.60 per share. The transaction valued at 5,694 led to the insider holds 329,856 shares of the business.
JENKINS DAVID A bought 9,528 shares of VTAK for $4,092 on Jan 22 ’24. The Executive Chairman and CEO now owns 320,328 shares after completing the transaction at $0.43 per share. On Jan 19 ’24, another insider, JENKINS DAVID A, who serves as the Executive Chairman and CEO of the company, bought 8,470 shares for $0.42 each. As a result, the insider paid 3,595 and bolstered with 310,800 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VTAK now has a Market Capitalization of 4267269 and an Enterprise Value of 1290376. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.81 while its Price-to-Book (P/B) ratio in mrq is 0.12. Its current Enterprise Value per Revenue stands at 2.96 whereas that against EBITDA is -0.15.
Stock Price History:
The Beta on a monthly basis for VTAK is -0.39, which has changed by -0.86410254 over the last 52 weeks, in comparison to a change of 0.22263205 over the same period for the S&P500. Over the past 52 weeks, VTAK has reached a high of $8.40, while it has fallen to a 52-week low of $0.31. The 50-Day Moving Average of the stock is 2.14%, while the 200-Day Moving Average is calculated to be -81.95%.
Shares Statistics:
The stock has traded on average 3.70M shares per day over the past 3-months and 681450 shares per day over the last 10 days, according to various share statistics. A total of 8.00M shares are outstanding, with a floating share count of 7.50M. Insiders hold about 6.33% of the company’s shares, while institutions hold 2.02% stake in the company. Shares short for VTAK as of 1730332800 were 183675 with a Short Ratio of 0.05, compared to 1727654400 on 46547. Therefore, it implies a Short% of Shares Outstanding of 183675 and a Short% of Float of 2.32.
